351. Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture
- Author
-
James D. Levine, Michael L. Joseph, R B Counts, Laurence A. Harker, and John M. Harlan
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Serine esterase activity ,Chemistry ,Immunology ,Cell Biology ,Hematology ,Biochemistry ,Molecular biology ,Umbilical vein ,Thrombin ,hemic and lymphatic diseases ,medicine ,Protein biosynthesis ,Factor VIII antigen ,circulatory and respiratory physiology ,51cr release ,medicine.drug - Abstract
We have examined the effects of purified human alpha-thrombin on factor VIII antigen (FVIII-Ag) release by human umbilical vein endothelial cells in culture. Alpha-thrombin induced a time and dose-dependent release of FVIII-Ag into supernatant medium. Alpha-thrombin-mediated FVIII-Ag release was not dependent on protein synthesis and was observed in both serum-free and serum-containing media. FVIII-Ag release, however, was prevented when the serine esterase activity of thrombin was inhibited. Pretreatment of human endothelial cells with alpha-thrombin, but not diisofluorophosphate-thrombin, prevented subsequent FVIII-Ag release by alpha-thrombin. Thrombin-mediated FVII- Ag release was not associated with significant 51Cr release from prelabeled endothelial monolayers. We conclude that alpha-thrombin induces release of preformed FVIII-Ag from human umbilical vein endothelial cells by a receptor-independent, nonlytic mechanism requiring serine esterase activity.
- Published
- 1982